Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles.
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000145:classification / Q000150:complications / Q000188:drug therapy*; D003071:Cognition / Q000187:drug effects; D003072:Cognition Disorders / Q000150:complications / Q000188:drug therapy; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D020441:Ginkgo biloba; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000627:therapeutic use*; D010936:Plant Extracts / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales / Q000592:standards; D012189:Retrospective Studies; D012720:Severity of Illness Index; D012919:Social Behavior; D013064:Speech Disorders / Q000150:complications / Q000188:drug therapy; D016896:Treatment Outcome; D014786:Vision Disorders / Q000150:complications / Q000188:drug therapy; D000096983:Ginkgo Extract
D018697:Nootropic Agents; D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract